Seoul Viosys begins mass production of coronavirus sterilizers

Seoul Viosys, a leading compound semiconductor solution provider in South Korea, announced that it has developed an opti...

September 7, 2020 | Monday | News
Korean CRO to conduct Ph III trial of Sinovac's Covid-19 vaccine candidate in Bangladesh

Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...

September 4, 2020 | Friday | News
PharmAbcine signs oncology agreement with Binex

South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, has announced&nbs...

September 3, 2020 | Thursday | News
Korean firm clinically evaluates blue light impact on skin

The Anti-Pollution Research Center of Amorepacific R&D Center, a South Korean beauty and cosmetics conglomerate...

September 4, 2020 | Friday | News
Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years

The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...

August 27, 2020 | Thursday | News
Celltrion initiates Ph I trial for COVID-19 drug in Korea

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved the company’s I...

August 27, 2020 | Thursday | News
Seoul Viosys promotes violeds to sterilize coronavirus

South Korea based Seoul Viosys, is promoting new Violeds technology solution, the world’s first ultraviolet LED te...

August 24, 2020 | Monday | News
KT Corp develops AI-based COVID-19 research

KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment...

August 21, 2020 | Friday | News
South Korean church donates plasma worth $83B for COVID-19 cure

At a time when the entire world is reeling under the impact of COVID-19, members of Shincheonji Church from South Korea ...

August 20, 2020 | Thursday | News
LG Chem & TransThera Bio to work on chronic inflammatory conditions

South Korean firm LG Chem Life Sciences, a division of LG Chem, and TransThera Biosciences Co. Ltd., a clinical-stage bi...

August 18, 2020 | Tuesday | News
Novavax, SK Bioscience announce COVID-19 vaccine collaboration

US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...

August 17, 2020 | Monday | News
Samsung Biologics invests $2B for further expansion

  South Korea based Samsung Biologics held an online press conference to announce its plans to break ground for a ...

August 13, 2020 | Thursday | News
Celltrion to launch antigen and antibody testing kits in US

South Korea based Celltrion Group recently announced the launch of two rapid kits for SARS-CoV-2 in the US by the third ...

August 14, 2020 | Friday | News
Mankind, Daewoong Pharma to use Niclosamide for COVID-19 treatment

Daewoong Pharmaceutical Co. Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mank...

August 11, 2020 | Tuesday | News
Merck & Hanmi to develop, commercialise therapy for NASH

Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...

August 12, 2020 | Wednesday | News
Samsung Biologics launches S-CHOice cell line expression technology

South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...

August 6, 2020 | Thursday | News
Macrogen obtains CE-IVD mark for COVID-19 test kit

Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...

August 4, 2020 | Tuesday | News
PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...

August 5, 2020 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls